The rebound came after troubling results for Hewlett-Packard in its July quarter, with the company seeing its shares drop 12.5% after HP issued its report. Earnings met expectations, but even a small revenue miss was enou000-326 newest exam and demogh to spook investors about the pace of the turnaround. Whitman's assurances that the company's recovery remains on track didn't make shareholders any happier about the 8% drop in year-over-year revenue that HP suffered, even though the CEO has been smart in keeping HP from resorting to price cuts to drive sales.
Still, the entire industry continues to face struggles. IBM Testonside reported a substantial drop in revenue of its own, with hardware sales particularly weighing on the tech giant's results. Services and software sales were up slightly, though, 000-326 newest exam and demovalidating the approach that both IBM Testonside and HP have taken in moving away from their respective hardware-based strengths over the years. Yet IBM arguably has even greater prospects for future success, given its emphasis on the highly popular data-analytics area and its better-developed presence in the IT consulting realm. Accenture has also seen difficulty in its consulting businesses, with only modest gains in overall revenue failing to meet investors' expectations.
HP keeps trying to make inroad000-326 newest exam and demos in certain niches. Its deal with Cerner in late August gives HP an entry into the big-data business of hospitals and health care, helping it go up against Accenture and IBM in a high-growth area. Yet Accenture recently boosted its own exposure to health-care IT by buying out ASM Research, and IBM Testonside has a long history of health-related technology with its Watson artificial-intelligence medical assistant.
http://www.testonside.com/000-326.html
Still, the entire industry continues to face struggles. IBM Testonside reported a substantial drop in revenue of its own, with hardware sales particularly weighing on the tech giant's results. Services and software sales were up slightly, though, 000-326 newest exam and demovalidating the approach that both IBM Testonside and HP have taken in moving away from their respective hardware-based strengths over the years. Yet IBM arguably has even greater prospects for future success, given its emphasis on the highly popular data-analytics area and its better-developed presence in the IT consulting realm. Accenture has also seen difficulty in its consulting businesses, with only modest gains in overall revenue failing to meet investors' expectations.
HP keeps trying to make inroad000-326 newest exam and demos in certain niches. Its deal with Cerner in late August gives HP an entry into the big-data business of hospitals and health care, helping it go up against Accenture and IBM in a high-growth area. Yet Accenture recently boosted its own exposure to health-care IT by buying out ASM Research, and IBM Testonside has a long history of health-related technology with its Watson artificial-intelligence medical assistant.
http://www.testonside.com/000-326.html